183
Participants
Start Date
January 31, 2004
Primary Completion Date
April 1, 2021
Study Completion Date
April 1, 2021
TheraSphere HUD
TheraSphere is FDA approved under a Humanitarian Use Device. It is considered a brachytherapy device that delivers intra-arterial radiation therapy using yttrium-90 microspheres directly to liver tumors.
University of Louisville Hospital / Norton Hospital, Louisville
Collaborators (1)
MDS Pharma Services
INDUSTRY
University of Louisville
OTHER